Background/Purpose: Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) continue to be a problem for clinicians worldwide. The objective of this study was to determine the changes in antibiograms of MRSA and their genotypic characteristics. Methods: The antibiograms of 162 MRSA isolates (52 from 2003 and 110 from 2008) from a tertiary hospital were analyzed by antimicrobial susceptibility tests, the Panton-Valentine leukocidin (PVL) and staphylococcal cassette chromosome mec (SCCmec) types were determined by polymerase chain reaction, and genetic relatedness by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Results: All the isolates were sensitive to vancomycin. Resistance to ciprofloxacin, clindamycin, erythromycin, and gentamicin remained high throughout the study period, although a small decrease was observed in 2008 for ciprofloxacin (96% to 90%) and gentamicin (90% to 83%). Similarly, a slight decrease in resistance toward fusidic acid (10% to 9%), linezolid (2% to 1%), rifampicin (8% to 4%), and teicoplanin (4% to 0%) was observed between 2003 and 2008. In contrast, there was a significant increase (p < 0.05) in resistance rates toward trimethoprim-sulfamethoxazole, netilmicin, and tetracycline between
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is an important bacterial pathogen associated with community (CA) and health care (HA) infections in Malaysia and worldwide. In a local study, the MRSA infection rate in a tertiary hospital was reported at 10.0 among 1000 hospital admissions. 1 The incidence of MRSA hospital infections in Japan was between 0.7 and 0.8 per 100 admissions from 1999 to 2003. 2 The rate of MRSA infections among hospitalized patients in the Asia-Pacific region was 45.9%. 3 The prevalence of MRSA in Malaysian hospitals has increased from 17% in 1986 4 to 44.1% in 2007. 5 An increase of 62% in MRSA was reported in the United States. 6 Because most MRSA is also resistant to many commonly used antibiotics, this has raised concern over the limited choice of antimicrobial agents for the treatment of life-threatening cases. This could lead to a prolonged hospital stay and increase the cost of care. 7, 8 A death rate of 34% within 30 days was observed among patients with MRSA infections as compared to 27% in patients with methicillin-sensitive Staphylococcus aureus (MSSA). 9 MRSA has evolved from methicillin-susceptible S. aureus via acquisition of mobile genetic elements called staphylococcal cassette chromosome mec (SCCmec) which has two essential components, the ccr gene complex (ccr) and the mec gene complex (mec). 10, 11 Previous studies in Malaysia have shown that HA-MRSA strains are associated with SCCmec type III whereas CA-MRSA is associated with SCCmec type IV and SCCmec type V. 5, 12, 13 There are no reports on the presence of other SCCmec types in Malaysia.
Panton-Valentine leukocidin (PVL) positive S. aureus is normally associated with CA-MRSA infections such as skin and mucous membrane infections, necrotizing pneumonia, urinary tract infections, and endocarditis. 13, 14 Rapid and discriminative subtyping methods are essential for determining the epidemiology of pathogenic strains and are useful in the design of rational pathogen control methods. Several methods are available and these include pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), direct repeat unit (DRU) typing, spa typing, and other polymerase chain reaction (PCR)-associated typing methods. 15 MLST has been shown to be useful in global epidemiologic studies of S. aureus. Ghaznavi-Rad et al 14 reported that more than 90% of MRSA infections in a tertiary hospital (HKL) in Malaysia belonged to MLST type ST239, whereas Ahmad et al 5 reported that most of the CA-MRSA reported in Malaysia belonged to MLST type ST30.
The changing epidemiology of MRSA is an important public health concern as infections caused by CA-MRSA are increasing. 16, 17 The objective of this study was to determine the changes in the antimicrobial susceptibility profiles of MRSA in a Malaysian tertiary teaching hospital between the years 2003 and 2008 and their genotypic characteristics as determined by PFGE, MLST, SCCmec, and PVL typing.
Materials and methods

Bacterial isolates
One hundred sixty-two nonduplicate MRSA isolates obtained from 158 patients and four healthcare workers (52 from 2003 and 110 from 2008) from the University Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia, were analyzed. UMMC is a 980-bed referral teaching hospital in Malaysia, which has orthopedic, pediatric, medical, surgical, obstetrics and gynecology, and psychiatry wards, and general intensive care units and neurology intensive care units. All MRSA isolates that could be revived from 2003 and 2008 stock cultures were included for analysis.
The isolates were identified as MRSA by standard methods in UMMC and were checked for purity before analysis. All the isolates were cultured in Luria-Bertani broth and stored in cryovials with 50% glycerol (Invitrogen, Grand Island, NY, USA) at e20 C and e85 C. Ninety-nine percent (161 of 162) of MRSA isolates were HA-MRSA. HA-MRSA refers to cases with positive culture obtained 48 hours after admission to the hospital, whereas CA-MRSA refers to cases with no association with healthcare setting. 18 The organisms were isolated from nasal swabs (n Z 37; 23%), tissue (n Z 13; 8%), wound swabs (n Z 28; 17%), urine (n Z 6; 4%), pus (n Z 12; 7%), body fluids (n Z 24; 15%), sputum (n Z 20; 12%), nasopharyngeal secretion (n Z 7; 4%), catheter tip (n Z 3; 2%), bone (n Z 4; 3%), blood (n Z 7; 4%), and chest tube "drainage" (n Z 1; 1%).
Antimicrobial susceptibility testing
The antimicrobial susceptibility of S. aureus isolates to 13 antimicrobial agents [vancomycin (30 mg 20, 21 and the results were interpreted as described previously. 20, 21 PCR detection of pvl gene and SCCmec types Genomic deoxyribonucleic acid (DNA) from MRSA was extracted by using the Wizard Genomic DNA purification kit (Promega, Madison, WI, USA). An aliquot (approximately 5 ng) was used as a DNA template for PCR analysis. Primers for the detection of pvl and SCCmec types were as previously described by Lina et al 22 and Milheirico et al 23 (Operon Biotechnologies GmBH, Cologne, Germany) were used.
Specific primers 4a1, 4a2, 4b1, 4b2, 4c1, 4c2, 4d1, and 4d2 as described by Hisata et al 24 and Okuma et al 25 were used for further subgrouping the SCCmec IV isolates. Eight positive-control MRSA isolates, NCTC10442, N315, 85/2082, JCSC4744, JCSC2172, JCSC4469, JCSC4788 and WI5 were used for SCCmec types I, II, III, IVa, IVb, IVc, IVd, and V, respectively (courtesy of Dr. Teruyo Ito, Japan). All PCR experiments were repeated once to confirm their reproducibility.
PFGE and MLST
PFGE was performed according to published work. 13 The chromosomal DNA was digested with 10 U SmaI followed by separation on CHEF DRIII (Bio-Rad, Hercules, CA, USA) in 0. 5Â Tris-borate-ethylenediaminetetraacetic acid (EDTA) at 14 C for 22 hours with pulse times of 5e60 seconds. Gels were photographed under ultraviolet light after staining with ethidium bromide (0.5 mg/mL).
Cluster analyses of PFGE profiles were analyzed with BioNumerics Version 6.0 (Applied Maths, Kortrijk, Belgium) based on the unweighted pair group method with arithmetic averages (UPGMA) with a position tolerance of 0.15. All PFGE profiles were assigned an arbitrary designation, and differences were defined by the Dice coefficient of similarity, F.
MLST was conducted on all SCCmec type IV, PVL positive, and representative isolates of each predominant PFGE type as described earlier by Enright et al. 26 The sequence types (STs) were assigned via the S. aureus MLST database (www. mlst.net).
Statistical analysis
A statistical software package STATISTICA (Version 8.0, StatSoft, Inc, Tulsa, OK, USA; http://www.statsoft.com/ products/) was used for data analysis. Comparison of certain variables was determined by the Fisher exact test. A p value <0.05 (two-tailed) was taken as the level of significance for the Fisher exact test.
Results
Antimicrobial susceptibility profiles
All the isolates were sensitive to vancomycin. Linezolid, teicoplanin, and rifampicin resistance remained low (1e5%). In contrast, resistance to ciprofloxacin, erythromycin, clindamycin, and gentamicin remained high throughout the study period. A summary of the antimicrobial resistance rates for MRSA isolates is shown in Table 1 . There was a significant increase in the rates of resistance to trimethoprim-sulfamethoxazole (p < 0. Most (n Z 109, 99%) of the 2008 isolates were sensitive to teicoplanin except for one nasopharyngeal secretion isolate, which showed intermediate susceptibility. Ninetynine percent (n Z 148) of the ciprofloxacin-resistant isolates were also resistant to erythromycin. Similarly, 99% (n Z 137) of gentamicin-resistant isolates were also resistant to erythromycin except for a nasal swab isolate MRSA0805-10 from a patient in the orthopedic ward.
A 
Genotypes of MRSA based on PFGE and MLST
SmaI-digested genomic DNA of the 162 MRSA isolates resulted in 84 distinct pulsed-field profiles (PFPs) comprising 10e18 restriction fragments (F Z 0.57e1.00). Based on the interpretation proposed by Tenover et al, 27 these 84 PFPs were further grouped into 63 PFGE types where closely related isolates with a similarity of more than 97% (1e2 band difference) was considered as a unique PFGE type (Fig. 1) . Most of the isolates were genetically related (F > 0.8). Thirty-five isolates shared the same PFGE type even though they were cultured from different sources and occasions (Fig. 1) . Some isolates from 6 years apart shared similar PFGE profiles, indicating the persistence of a particular genotype.
MLST was performed on all SCCmec type IV (n Z 15), SCCmec type V (n Z 1), and representative isolates for each predominant PFGE type (n Z 18). This identified five STs (ST239, ST772, ST22, ST6, and ST1178). MLST type ST239 was observed from both 2003 (n Z 9) and 2008 (n Z 9) isolates, whereas new MLST types ST772 (n Z 1), ST22 (n Z 12), ST6 (n Z 1), and ST1178 (n Z 2) were identified among the 2008 isolates. All 12 ST22 isolates carried SCCmec type IV (Table 2) .
Combined analysis
A dendrogram based on combined PFPs and resistotypes is shown in Fig. 2 . All 162 MRSA isolates were differentiated into 110 combined subtypes. Some isolates (i.e., MRSA0807-19, MRSA0808-19, MRSA0305-10, and MRSA0312-17) shared the same combined subtypes even though they were cultured independently from different time periods and sources. Based on 70% similarity, five clusters were observed. Cluster 1 consists of 127 isolates; Clusters 2 and 3 consist of three isolates; Cluster 4 consists of 12 isolates; and Cluster 5 consists of seven isolates. Nine isolates were not grouped into any of the clusters.
Fifty-nine isolates within Cluster 1 were clonally related (shared more than 80% similarity) although they were from different sources and years. These isolates were also resistant to gentamicin, erythromycin, and clindamycin and 98% of them were of SCCmec type III. Some isolates that were indistinguishable by PFGE were further differentiated in the combined analysis as they had different resistotypes. For example, MRSA0801-26, MRSA0805-22, MRSA0812-37, MRSA0309-10, MRSA0809-25, MRSA0806-33, MRSA0810-9, MRSA0807-19, MRSA0808-19, MRSA0305-10, and MRSA0312-17 were further differentiated by their resistotypes although they shared similar PFGE profiles. Based on PFGE analysis, the only SCCmec type V isolate was clonally related (shared 81.8% similarity) with one SCCmec type III (MRSA0807-13). However, they only shared 79.8% in the combined analysis as these two isolates had unique resistotypes.
Among the 15 SCCmec type IV isolates, one was grouped in Cluster 1, 12 in Cluster 4, and two isolates were not grouped in any cluster. The 12 isolates within Cluster 4 belonged to MLST type ST22, with seven of them sharing the same resistotype (Fig. 2, Table 2 ).
Two teicoplanin-resistant isolates (MRSA0311-23 and MRSA0312-35) shared 78.2% similarity and were grouped in Cluster 1 (Fig. 2 ). Both were SCCmec type III but had different resistotypes. MRSA0311-23 was resistant to erythromycin, gentamicin, ciprofloxacin, oxacillin, and trimethoprim-sulfamethoxazole, whereas MRSA0312-35 was resistant to mupirocin, tetracycline, oxacillin, and fusidic acid.
Discussion
Infections caused by MRSA continue to be a problem in Malaysian hospitals. Although several studies have documented the antimicrobial resistance trends of MRSA in other countries, 6, 7 reports comparing resistance trends and In this study, tetracycline-resistant MRSA had significantly increased over a 6-year period (p < 0.01), possibly because of an increased usage of tetracycline or doxycycline in the hospital. Thong et al 13 reported tetracycline resistance rate of MRSA at 32% in the year 2003. The increase in the tetracycline resistant rate has also been reported in another Malaysian hospital. 12 There was a significant increase in resistance rates to trimethoprimsulfamethoxazole from 2003 to 2008. This was probably also due to an increased usage of trimethoprimsulfamethoxazole in the hospital (unpublished hospital records). Similar high resistance rates were reported by Neela et al 12 In addition, the rates of resistance to erythromycin reported in this study remained high (96%) in 2003 and 2008. This is concordant with previously reported erythromycin resistance rates of 81.2e96.0%. 5, 12, 13 Both inducible and constitutive MLS B phenotypes were observed among erythromycin-resistant isolates, with most (96%) showing the i-MLS B phenotype. The prevalence of i-MLS B isolates (92%) was much higher when compared with the 63% reported in Korea (in 2004) . 28 The resistance rates of clindamycin had increased slightly from 94% (in 2003) to 96% (in 2008) over 6 years. This was much higher than that previously reported in Malaysia by Ahmad et al 5 (0%), Al-Talib et al 1 (6%), and Neela et al 12 (0%).
Even though SCCmec type II MRSA isolates are predominant in Korea and Japan, 10, 11 they are absent in Malaysia. The predominant SCCmec in Malaysia is SCCmec type III (90%), and this SCCmec type III is also common in hospitals in Singapore, Thailand, Taiwan, and Indonesia.
11,29 All 15 SCCmec type IV MRSA isolates (9%) were HA-MRSA (unpublished hospital records), although SCCmec type IV MRSA isolates were mostly associated with CA-MRSA. 5 SCCmec type IV HA-MRSA has been previously reported in Denmark. 30 In addition, all SCCmec type IV isolates were susceptible to rifampicin, mupirocin, teicoplanin, and vancomycin. This is in agreement with a previous report by Ahmad et al 5 that SCCmec type IV isolates are susceptible to four or more non-b-lactam antibiotics. Similarly, D'Souza et al 31 also reported that 83% of their SCCmec type IV isolates from India were susceptible to many classes of antimicrobials agents. Two of 12 ST22 SCCmec type IV MRSA isolates reported here were resistant to gentamicin. This differs from the report of Ahmad et al 5 (Malaysia) and Conceição et al 32 (Atlantic Azores islands), where the ST22 isolates were sensitive to gentamicin and tetracycline.
One SCCmec type IV isolate (MRSA0805-10) shared similar PFPs with two SCCmec type III isolates (MRSA0808-17 and MRSA0811-11) but had different resistotypes. Similarly, some SCCmec type III and SCCmec type IV isolates shared more than 90% similarity by PFGE and resistotypes. This suggests that these isolates might have acquired a different mec and ccr gene complex, resulting in differences in SCCmec types even though they shared a similar PFGE type.
Most (80%) of the SCCmec type IV MRSA isolates belonged to MLST type ST22, followed by ST1178 (13.3%) and ST6 (6.67%). The presence of ST22, ST1178, and multisensitive ST6 in SCCmec type IV MRSA isolates from the same hospital had been previously reported by Sam et al. 33 The presence of a clone with SCCmec type IV and ST22 genotype has also been reported in Italy, Australia, India, and Iran. 31,34e36 a Sensitive to all the antimicrobial agents tested. CIP Z ciprofloxacin; CN Z gentamicin; DA Z clindamycin; ERY Z erythromycin; FD Z fusidic acid; LZD Z linezolid; MLST Z multilocus sequence typing; NET Z netilmicin; PFGE Z pulsed-field gel electrophoresis; SXT Z trimethoprim-sulfamethoxazole; TE Z tetracycline. The SCCmec IV: ST22 from the Atlantic Azores islands belonged to SCCmec type IVh (Conceição et al 32 ) , whereas all the SCCmec type IV: ST22 in the current study were SCCmec type IVa. Even though ST30 (SCCmec type IV) and ST1 are known as pandemic MRSA clones, 37 they are absent in this study.
The high ciprofloxacin resistant rates among SCCmec type IV isolates in this hospital might be because of the high usage of antibiotics in the hospital (unpublished data). High erythromycin-and trimethoprim-sulfamethoxazole resistance rates were also observed among SCCmec type IV isolates, and similar observations had been previously reported in a hospital in Southern Iran by Japoni et al. 36 Coombs et al 34 reported the presence of SCCmec type IV, MLST type ST22 isolates with erythromycin and ciprofloxacin resistance among MRSA isolated from western Australia.
The only SCCmec type V isolate (MRSA0812-36) found in this study was CA-MRSA, PVL negative, ST772 and MDR. SCCmec type V was first reported in CA-MRSA from nasal swabs of healthy local university students. 38 Ahmad et al 5 and Otter and French 39 proposed gentamicin and ciprofloxacin, respectively, as phenotypic markers for CA-MRSA. However, the only CA-MRSA isolates in this study were resistant to both the antimicrobial agents. Therefore, both antimicrobial agents might not be suitable to be used as the phenotypic marker of CA-MRSA in this tertiary hospital. MLST type ST239 remained as the predominant clone in this tertiary hospital. Similarly, more than 90% of MRSA isolates from another tertiary hospital in Malaysia belonged to this pandemic clone. 15 Combined analysis based on PFPs and resistotypes showed that most of the MRSA isolates were clonally related even though they were cultured at different times. This suggests that several clones of MRSA isolates were circulating in this tertiary hospital during the study period. Some other 2003 and 2008 isolates also shared similar combined subtypes and this further implies persistence of certain clones within the hospital environment. The presence of three indistinguishable clinical isolates, which were cultured during the same month (July) but from different wards, further supports the notion of the circulation of a particular clone in the hospital. The tetracycline and trimethoprim-sulfamethoxazole isolates might be a part of the persistent clone in the hospital environment.
In conclusion, correlation between PFGE profiles and resistotypes was observed. Isolates with indistinguishable PFGE profiles often have similar antibiotic susceptibility patterns even though there are variations in certain antibiograms in distinct clones of MRSA. The antibiotic resistance rates had increased over the years and the persistence of MDR isolates remains a problem. Although MRSA with SCCmec type III with MLST type ST239 is predominant in Malaysia, SCCmec type IV with MLST type ST22 is gaining prominence. The MDR MRSA clinical isolates from UMMC were mostly genetically related, suggesting that few predominant clones of the species are involved in infection.
